Article
Effects of Metformin on Transcriptomic and Metabolomic Profiles in Breast Cancer Survivors Enrolled in the Randomized Placebo-Controlled MetBreCS Trial
2023-10-19
Abstract excerpt
<h4>Background: </h4> Metformin reduces the incidence of breast cancer in patients with type 2 diabetes and obesity. However, our knowledge about the effects of metformin on cancer recurrence in breast tissue is limited. Therefore, in this study, we examined the breast tissue gene expression changes by metformin in breast cancer survivors. <h4>Methods: </h4> Within the randomized placebo-controlled MetBreCS trial,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9a46ea1e-0469-57c1-8c07-e6f0bb3c3905
- DOI
- 10.21203/rs.3.rs-3404464/v1
